Rocket Pharma Reaps $180M From Sale of FDA Drug Review Fast Pass

Rocket Pharmaceuticals received the rare pediatric disease priority review voucher with the accelerated FDA approval for Kresladi in March. The non-dilutive capital from the voucher’s sale will support a pipeline that includes a gene therapy in pivotal clinical testing for the rare genetic disorder Danon disease. The post Rocket Pharma Reaps $180M From Sale of…

Read More

Weekend Reading

GLP-1 and cancer.Healthcare mortgages for gene therapies.Argentia vs. Chile: battle of the economies.Medicaid work rules explained.Watch the World Cup in English or en Español?

Read More

Bot vs. Bot: Why Healthcare AI Progress Might Be Stuck

The healthcare industry is spending more than ever on AI — but according to executives from Oracle Health, HCA Healthcare and BJC Health, much of that investment could be wasted. During a panel this week at HFMA’s annual conference, they argued that no amount of sophisticated tech can overcome a broken, antiquated data foundation. The…

Read More

California Health Worker Union, Hospital Association Tout Dueling Ballot Initiatives

The issue of affordability has reignited a long-simmering battle between California’s medical industry and one of its largest health worker unions.  SEIU-United Healthcare Workers West, with approximately 120,000 members, has put forward two ballot initiatives to cap the pay of medical executives and require community clinics to spend the vast bulk of their revenues on…

Read More